APO RESEARCH · REPORT
Activin-A
Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.
Product & engineering
Understand the product.
Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.
Selected research
Market Structure
Global Activin-A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological activities, including mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis and roles in reproductive physiology. Activin isoforms and other members of the TGF-beta superfamily exert their biological effects by binding to heteromeric complexes of a type I and a type II serine-threonine kinase receptor, both of which are essential for signal transduction.
Major players in the industry are Merck Millipore, Thermo Fisher Scientific and bio-techne, which accounted for 26.80%, 12.00% and 10.32% of revenue in 2019, respectively. By region, North America has the highest share of income, at 52.22 percent in 2019.
This report provides an overview of the global Activin-A market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Activin-A and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Activin-A sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Activin-A market size, projected growth trends, production technologies, key applications, and end-use industries.
Activin-A Segment by Company
Merck Millipore
Thermo Fisher Scientific
Bio-Techne
StemRD
Prospec
Proteintech Group
Ajinomoto
Enzo Life Sciences
IBL
STEMCELL
Sino Biological
PeproTech
ReproCELL
Activin-A Segment by Type
Activin-A Human
Activin-A Mouse(Rat)
Activin-A Segment by Application
Commercial Research
Academic Research
Activin-A Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Activin-A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Activin-A and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Activin-A.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Activin-A market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Activin-A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Activin-A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Activin-A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Activin-A Human
- Activin-A Mouse(Rat)
Applications
- Commercial Research
- Academic Research
Companies covered
- Merck Millipore
- Thermo Fisher Scientific
- Bio-Techne
- StemRD
- Prospec
- Proteintech Group
- Ajinomoto
- Enzo Life Sciences
- IBL
- STEMCELL
- Sino Biological
- PeproTech
- ReproCELL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Activin-A Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Activin-A Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Activin-A Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Activin-A Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Activin-A Market Dynamics
- 2.1 Activin-A Industry Trends
- 2.2 Activin-A Industry Drivers
- 2.3 Activin-A Industry Opportunities and Challenges
- 2.4 Activin-A Industry Restraints
3 Activin-A Market by Manufacturers
- 3.1 Global Activin-A Revenue by Manufacturers (2021-2026)
- 3.2 Global Activin-A Sales by Manufacturers (2021-2026)
- 3.3 Global Activin-A Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Activin-A Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Activin-A Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Activin-A Manufacturers, Product Type & Application
- 3.7 Global Activin-A Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Activin-A Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Activin-A Players Market Share by Revenue in 2025
- 3.8.3 2025 Activin-A Tier 1, Tier 2, and Tier 3
4 Activin-A Market by Type
- 4.1 Activin-A Type Introduction
- 4.1.1 Activin-A Human
- 4.1.2 Activin-A Mouse(Rat)
- 4.2 Global Activin-A Sales by Type
- 4.2.1 Global Activin-A Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Activin-A Sales by Type (2021-2032)
- 4.2.3 Global Activin-A Sales Market Share by Type (2021-2032)
- 4.3 Global Activin-A Revenue by Type
- 4.3.1 Global Activin-A Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Activin-A Revenue by Type (2021-2032)
- 4.3.3 Global Activin-A Revenue Market Share by Type (2021-2032)
5 Activin-A Market by Application
- 5.1 Activin-A Application Introduction
- 5.1.1 Commercial Research
- 5.1.2 Academic Research
- 5.2 Global Activin-A Sales by Application
- 5.2.1 Global Activin-A Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Activin-A Sales by Application (2021-2032)
- 5.2.3 Global Activin-A Sales Market Share by Application (2021-2032)
- 5.3 Global Activin-A Revenue by Application
- 5.3.1 Global Activin-A Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Activin-A Revenue by Application (2021-2032)
- 5.3.3 Global Activin-A Revenue Market Share by Application (2021-2032)
6 Global Activin-A Sales by Region
- 6.1 Global Activin-A Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Activin-A Sales by Region (2021-2032)
- 6.2.1 Global Activin-A Sales by Region (2021-2026)
- 6.2.2 Global Activin-A Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Activin-A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Activin-A Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Activin-A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Activin-A Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Activin-A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Activin-A Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Activin-A Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Activin-A Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Activin-A Revenue by Region
- 7.1 Global Activin-A Revenue by Region
- 7.1.1 Global Activin-A Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Activin-A Revenue by Region (2021-2026)
- 7.1.3 Global Activin-A Revenue by Region (2027-2032)
- 7.1.4 Global Activin-A Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Activin-A Revenue (2021-2032)
- 7.2.2 North America Activin-A Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Activin-A Revenue (2021-2032)
- 7.3.2 Europe Activin-A Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Activin-A Revenue (2021-2032)
- 7.4.2 Asia-Pacific Activin-A Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Activin-A Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Activin-A Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Merck Millipore
- 8.1.1 Merck Millipore Company Information
- 8.1.2 Merck Millipore Business Overview
- 8.1.3 Merck Millipore Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Millipore Activin-A Product Portfolio
- 8.1.5 Merck Millipore Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Activin-A Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Bio-Techne
- 8.3.1 Bio-Techne Company Information
- 8.3.2 Bio-Techne Business Overview
- 8.3.3 Bio-Techne Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bio-Techne Activin-A Product Portfolio
- 8.3.5 Bio-Techne Recent Developments
- 8.4 StemRD
- 8.4.1 StemRD Company Information
- 8.4.2 StemRD Business Overview
- 8.4.3 StemRD Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 StemRD Activin-A Product Portfolio
- 8.4.5 StemRD Recent Developments
- 8.5 Prospec
- 8.5.1 Prospec Company Information
- 8.5.2 Prospec Business Overview
- 8.5.3 Prospec Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Prospec Activin-A Product Portfolio
- 8.5.5 Prospec Recent Developments
- 8.6 Proteintech Group
- 8.6.1 Proteintech Group Company Information
- 8.6.2 Proteintech Group Business Overview
- 8.6.3 Proteintech Group Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Proteintech Group Activin-A Product Portfolio
- 8.6.5 Proteintech Group Recent Developments
- 8.7 Ajinomoto
- 8.7.1 Ajinomoto Company Information
- 8.7.2 Ajinomoto Business Overview
- 8.7.3 Ajinomoto Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Ajinomoto Activin-A Product Portfolio
- 8.7.5 Ajinomoto Recent Developments
- 8.8 Enzo Life Sciences
- 8.8.1 Enzo Life Sciences Company Information
- 8.8.2 Enzo Life Sciences Business Overview
- 8.8.3 Enzo Life Sciences Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Enzo Life Sciences Activin-A Product Portfolio
- 8.8.5 Enzo Life Sciences Recent Developments
- 8.9 IBL
- 8.9.1 IBL Company Information
- 8.9.2 IBL Business Overview
- 8.9.3 IBL Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 IBL Activin-A Product Portfolio
- 8.9.5 IBL Recent Developments
- 8.10 STEMCELL
- 8.10.1 STEMCELL Company Information
- 8.10.2 STEMCELL Business Overview
- 8.10.3 STEMCELL Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 STEMCELL Activin-A Product Portfolio
- 8.10.5 STEMCELL Recent Developments
- 8.11 Sino Biological
- 8.11.1 Sino Biological Company Information
- 8.11.2 Sino Biological Business Overview
- 8.11.3 Sino Biological Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Sino Biological Activin-A Product Portfolio
- 8.11.5 Sino Biological Recent Developments
- 8.12 PeproTech
- 8.12.1 PeproTech Company Information
- 8.12.2 PeproTech Business Overview
- 8.12.3 PeproTech Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 PeproTech Activin-A Product Portfolio
- 8.12.5 PeproTech Recent Developments
- 8.13 ReproCELL
- 8.13.1 ReproCELL Company Information
- 8.13.2 ReproCELL Business Overview
- 8.13.3 ReproCELL Activin-A Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 ReproCELL Activin-A Product Portfolio
- 8.13.5 ReproCELL Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Activin-A Value Chain Analysis
- 9.1.1 Activin-A Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Activin-A Production Mode & Process
- 9.2 Activin-A Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Activin-A Distributors
- 9.2.3 Activin-A Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst